21+
Age Verification
You must be 21 years of age or older to enter this site.
By entering, you confirm you are 21 years of age or older.
You must be 21 years of age or older to enter this site.
By entering, you confirm you are 21 years of age or older.
KLOW is a precisely formulated quad-peptide research blend combining four distinct bioactive peptides: TB-500 (thymosin beta-4 fragment, 10mg), BPC-157 (pentadecapeptide, 10mg), GHK-Cu (copper tripeptide, 50mg), and KPV (alpha-MSH derivative, 10mg). This multi-peptide formulation enables researchers to study the combined activity profiles of these complementary compounds in a single reconstitution.
Each component has been individually characterized in published peer-reviewed literature. The blend is manufactured under strict quality control protocols, with each peptide component verified to ≥99% purity via reverse-phase HPLC before formulation. The final lyophilized product undergoes additional quality verification to confirm component ratios and overall purity.
AXOM KLOW 80mg is supplied as a lyophilized powder in a sealed glass vial. Total peptide content is 80mg per vial. For research and laboratory use only.
Four distinct bioactive peptides — TB-500, BPC-157, GHK-Cu, and KPV — combined in a single vial for multi-target research applications.
Each component individually verified to ≥99% purity before blending. Total 80mg content: TB-500 10mg, BPC-157 10mg, GHK-Cu 50mg, KPV 10mg.
≥99% HPLC-verified purity with full COA documentation. Every lot independently tested by third-party analytical laboratories.
Comprehensive review of thymosin beta-4 (TB-500 parent compound) covering its molecular properties, receptor interactions, and in-vitro activity profiles across multiple tissue models. Characterizes the peptide's role in actin sequestration and its downstream signaling pathways.
Review of BPC-157 characterizing the pentadecapeptide's stability profile and receptor binding characteristics in gastrointestinal tissue models. Documents the compound's unique resistance to enzymatic degradation and its interaction with multiple growth factor pathways.
Analysis of the copper tripeptide GHK-Cu and its gene expression modulation profile. Documents the peptide's ability to influence over 4,000 genes in human cell culture models, with particular focus on extracellular matrix protein regulation and metalloproteinase activity.
Characterization of the KPV tripeptide (Lys-Pro-Val) derived from the C-terminal region of alpha-MSH. Documents the peptide's NF-kB modulation activity and its receptor-independent signaling mechanisms in in-vitro inflammatory models.
| Product Name | KLOW 80mg (Quad-Peptide Research Blend) |
| Total Content | 80mg per vial |
| Component 1 | TB-500 (Thymosin Beta-4 Fragment) — 10mg | CAS: 77591-33-4 | MW: ~4,963 Da |
| Component 2 | BPC-157 (Body Protection Compound) — 10mg | CAS: 137525-51-0 | MW: ~1,419 Da |
| Component 3 | GHK-Cu (Copper Tripeptide) — 50mg | CAS: 49557-75-7 | MW: ~403.93 Da |
| Component 4 | KPV (Alpha-MSH Derivative) — 10mg | CAS: 67727-97-3 | MW: ~342.43 Da |
| Purity | ≥99% per component (Reverse-Phase HPLC) |
| Form | Lyophilized white powder |
| Solubility | Soluble in sterile water, bacteriostatic water |
| Endotoxin | <1 EU/μg (LAL method) |
| Certification | COA included with every order |
| Intended Use | For research and laboratory use only |
KLOW 80mg is supplied as a lyophilized powder and should be reconstituted with sterile bacteriostatic water (BAC water) for research applications.
All orders ship within the continental United States via USPS or UPS. Peptides are shipped at ambient temperature — lyophilized peptides are stable during transit. Free shipping on orders over $250.
